Vergoeding 2018-2022 voor ATC-subgroep N06AX : Overige antidepressiva
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| N06AX03 Mianserine | 38.852 | 41.612 | 25.827 | 24.397 | 17.913 |
| N06AX05 Trazodon (Trazolan ®) | 544.530 | 561.220 | 600.720 | 641.210 | 659.680 |
| N06AX11 Mirtazapine (Remeron ®) | 1.545.700 | 1.528.200 | 1.558.900 | 1.700.400 | 1.705.400 |
| N06AX12 Bupropion (Wellbutrin ®) | 5.078.600 | 5.443.900 | 5.778.200 | 4.764.900 | 4.868.000 |
| N06AX16 Venlafaxine (Efexor ®) | 3.505.600 | 3.706.700 | 3.774.600 | 3.538.300 | 3.862.900 |
| N06AX21 Duloxetine (Cymbalta ®) | 2.972.900 | 1.755.000 | 1.818.000 | 1.682.900 | 1.762.400 |
| N06AX22 Agomelatine (Valdoxan ®) | 855.280 | 677.550 | 506.580 | 431.790 | 427.950 |
| N06AX26 Vortioxetine (Brintellix ®) | 1.066.000 | 1.376.300 | 1.545.900 | 1.585.200 | 1.684.100 |
| Totaal | 15.607.462 | 15.090.482 | 15.608.727 | 14.369.097 | 14.988.343 |